Anti-Inflammatory Activity of Human IgG4 Antibodies by Dynamic Fab Arm Exchange by van der Neut Kolfschoten, Marijn, Schuurman, Janine, Losen, Mario, Bleeker, Wim K., Martínez-Martínez, Pilar, Vermeulen, Ellen, Bleker, Tamara H. den, Wiegman, Luus, Vink, Tom, Aarden, Lucien A., De Baets, Marc H., van de Winkel, Jan G. J., Aalberse, Rob C., Parren, Paul W. H. I.

Get full text

Traces of pFc’ in IVIG interact with human IgG Fc domains and counteract aggregation by Rispens, Theo, Himly, Martin, Heer, Pleuni Ooievaar-De, Bleker, Tamara H. den, Aalberse, Rob C.

Get full text

Species-specific determinants in the IgG CH3 domain enable Fab-arm exchange by affecting the noncovalent CH3-CH3 interaction strength by Labrijn, Aran F, Rispens, Theo, Meesters, Joyce, Rose, Rebecca J, den Bleker, Tamara H, Loverix, Stefan, van den Bremer, Ewald T J, Neijssen, Joost, Vink, Tom, Lasters, Ignace, Aalberse, Rob C, Heck, Albert J R, van de Winkel, Jan G J, Schuurman, Janine, Parren, Paul W H I

Get full text

Crystal structure of the human IgG4 C(H)3 dimer reveals the role of Arg409 in the mechanism of Fab-arm exchange by Davies, Anna M, Rispens, Theo, den Bleker, Tamara H, McDonnell, James M, Gould, Hannah J, Aalberse, Rob C, Sutton, Brian J

Get full text

Crystal structure of the human IgG4 CH3 dimer reveals the role of Arg409 in the mechanism of Fab-arm exchange by Davies, Anna M., Rispens, Theo, den Bleker, Tamara H., McDonnell, James M., Gould, Hannah J., Aalberse, Rob C., Sutton, Brian J.

Get full text

Hybrid IgG4/IgG4 Fc antibodies form upon ‘Fab-arm’ exchange as demonstrated by SDS-PAGE or size-exclusion chromatography by Rispens, Theo, den Bleker, Tamara H., Aalberse, Rob C.

Get full text

Fc–Fc interactions of human IgG4 require dissociation of heavy chains and are formed predominantly by the intra-chain hinge isomer by Rispens, Theo, Meesters, Joyce, den Bleker, Tamara H., Ooijevaar-De Heer, Pleuni, Schuurman, Janine, Parren, Paul W.H.I., Labrijn, Aran, Aalberse, Rob C.

Get full text

Corrigendum to “Traces of pFc’ in IVIG interact with human IgG Fc domains and counteract aggregation” [Eur J Pharm Sci 40(1) (2010) 62–68] by Rispens, Theo, Himly, Martin, Ooievaar-De Heer, Pleuni, den Bleker, Tamara H., Aalberse, Rob C.

Get full text